Hadas Galon Tilleman

Hadas Galon Tilleman

Auto-generated profile, based on publicly available information

Hadas Galon Tilleman

Research & Drug Discovery, Compugen Ltd., Holon, Israel

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2018 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
VJVukasin M. Jovanovic
Vukasin M. Jovanovic
Ahmad SaltiAhmad Salti
Ahmad Salti
HTHadas Tilleman
Hadas Tilleman
KZKsenija Zega
Ksenija Zega
MJMarin M. Jukic
Marin M. Jukic
CBClaude Brodski
Claude Brodski
The embryonic formation of midbrain dopaminergic (mDA) neuronsin vivoprovides critical guidelines for thein vitrodifferentiation of mDA neurons from stem cells, which are currently being developed for Parkinson's disease cell replacement therapy. Bone morphogenetic protein (BMP)/SMAD inhibition is routinely used during early steps of stem cell differentiation protocols, including for the generation of mDA neurons. However, the function of the BMP/SMAD pathway forin vivospecification of mammalian mDA neurons is virtually unknown. Here, we report that BMP5/7-deficient mice (Bmp5−/−;Bmp7−/−) lack mDA neurons due to reduced neurogenesis in the mDA progenitor domain. As molecular mechanisms accounting for these alterations inBmp5−/−;Bmp7−/−mutants, we have identified expression changes of the BMP/SMAD target genes MSX1/2 (msh homeobox 1/2) and SHH (sonic hedgehog). Conditionally inactivating SMAD1 in neural stem cells of micein vivo(Smad1Nes) hampered the differentiation of progenitor cells into mDA neurons by preventing cell cycle exit, especially of TH+SOX6+(tyrosine hydroxylase, SRY-box 6) and TH+GIRK2+(potassium voltage-gated channel subfamily-J member-6) substantia nigra neurons. BMP5/7 robustly increased thein vitrodifferentiation of human induced pluripotent stem cells and induced neural stem cells to mDA neurons by up to threefold. In conclusion, we have identified BMP/SMAD signaling as a novel critical pathway orchestrating essential steps of mammalian mDA neurogenesisin vivothat balances progenitor proliferation and differentiation. Moreover, we demonstrate the potential of BMPs to improve the generation of stem-cell-derived mDA neuronsin vitro, highlighting the importance of sequential BMP/SMAD inhibition and activation in this process.SIGNIFICANCE STATEMENTWe identify bone morphogenetic protein (BMP)/SMAD signaling as a novel essential pathway regulating the development of mammalian midbrain dopaminergic (mDA) neuronsin vivoand provide insights into the molecular mechanisms of this process. BMP5/7 regulate MSX1/2 (msh homeobox 1/2) and SHH (sonic hedgehog) expression to direct mDA neurogenesis. Moreover, the BMP signaling component SMAD1 controls the differentiation of mDA progenitors, particularly to substantia nigra neurons, by directing their cell cycle exit. Importantly, BMP5/7 increase robustly the differentiation of human induced pluripotent and induced neural stem cells to mDA neurons. BMP/SMAD are routinely inhibited in initial stages of stem cell differentiation protocols currently being developed for Parkinson's disease cell replacement therapies. Therefore, our findings on opposing roles of the BMP/SMAD pathway duringin vitromDA neurogenesis might improve these procedures significantly.

9 April 2024 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
AMAssaf Menachem
Assaf Menachem
ZAZoya Alteber
Zoya Alteber
GCGady Cojocaru
Gady Cojocaru
TKTal Fridman Kfir
Tal Fridman Kfir
DBDan Blat
Dan Blat
EOEran Ophir
Eran Ophir
Recombinant cytokines have limited anticancer efficacy mostly due to a narrow therapeutic window and systemic adverse effects. IL18 is an inflammasome-induced proinflammatory cytokine, which enhances T- and NK-cell activity and stimulates IFNγ production. The activity of IL18 is naturally blocked by a high-affinity endogenous binding protein (IL18BP). IL18BP is induced in the tumor microenvironment (TME) in response to IFNγ upregulation in a negative feedback mechanism. In this study, we found that IL18 is upregulated in the TME compared with the periphery across multiple human tumors and most of it is bound to IL18BP. Bound IL18 levels were largely above the amount required for T-cell activation in vitro, implying that releasing IL18 in the TME could lead to potent T-cell activation. To restore the activity of endogenous IL18, we generated COM503, a high-affinity anti-IL18BP that blocks the IL18BP:IL18 interaction and displaces precomplexed IL18, thereby enhancing T- and NK-cell activation. In vivo, administration of a surrogate anti-IL18BP, either alone or in combination with anti-PD-L1, resulted in significant tumor growth inhibition and increased survival across multiple mouse tumor models. Moreover, the anti-IL18BP induced pronounced TME-localized immune modulation including an increase in polyfunctional nonexhausted T- and NK-cell numbers and activation. In contrast, no increase in inflammatory cytokines and lymphocyte numbers or activation state was observed in serum and spleen. Taken together, blocking IL18BP using an Ab is a promising approach to harness cytokine biology for the treatment of cancer.

17 June 2026
Verified
Other
Open access
AMAssaf Menachem
Assaf Menachem
ZAZoya Alteber
Zoya Alteber
GCGady Cojocaru
Gady Cojocaru
TKTal Fridman Kfir
Tal Fridman Kfir
DBDan Blat
Dan Blat
EOEran Ophir
Eran Ophir
Supplemental Figure S3. Antitumor activity of anti-mouse-IL-18BP Ab in mice studies.

4 June 2024
Verified
Other
Open access
PDF file
AMAssaf Menachem
Assaf Menachem
ZAZoya Alteber
Zoya Alteber
GCGady Cojocaru
Gady Cojocaru
TKTal Fridman Kfir
Tal Fridman Kfir
DBDan Blat
Dan Blat
EOEran Ophir
Eran Ophir
Supplemental Figure S4. Anti-IL-18BP Ab induced immunogenic memory response in E0771 tumor model.

4 June 2024
Verified
Other
Open access
PDF file
AMAssaf Menachem
Assaf Menachem
ZAZoya Alteber
Zoya Alteber
GCGady Cojocaru
Gady Cojocaru
TKTal Fridman Kfir
Tal Fridman Kfir
DBDan Blat
Dan Blat
EOEran Ophir
Eran Ophir
Supplemental Figure S3. Antitumor activity of anti-mouse-IL-18BP Ab in mice studies.

4 June 2024
Verified
Other
Open access
PDF file
AMAssaf Menachem
Assaf Menachem
ZAZoya Alteber
Zoya Alteber
GCGady Cojocaru
Gady Cojocaru
TKTal Fridman Kfir
Tal Fridman Kfir
DBDan Blat
Dan Blat
EOEran Ophir
Eran Ophir
Supplemental Figure S4. Anti-IL-18BP Ab induced immunogenic memory response in E0771 tumor model.